As of May 31
| -0.0495 / -8.39%|
The 1 analysts offering 12-month price forecasts for Fresh Tracks Therapeutics Inc have a median target of 12.00, with a high estimate of 12.00 and a low estimate of 12.00. The median estimate represents a +2,120.17% increase from the last price of 0.54.
The current consensus among 1 polled investment analysts is to Buy stock in Fresh Tracks Therapeutics Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.